129 related articles for article (PubMed ID: 25198571)
21. Antimüllerian hormone and polycystic ovary syndrome.
Lin YH; Chiu WC; Wu CH; Tzeng CR; Hsu CS; Hsu MI
Fertil Steril; 2011 Jul; 96(1):230-5. PubMed ID: 21549367
[TBL] [Abstract][Full Text] [Related]
22. Threshold values of follicle count for the definition of PCO.
Perales-Puchalt A
Hum Reprod; 2012 May; 27(5):1543; author reply 1543-4. PubMed ID: 22398257
[No Abstract] [Full Text] [Related]
23. A single cut-off value of anti-Müllerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women.
Mahboobifard F; Rahmati M; Ramezani Tehrani F
Hum Reprod; 2022 Mar; 37(3):621-622. PubMed ID: 35106559
[No Abstract] [Full Text] [Related]
24. Reply: A single cut-off value of anti-Mullerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women.
Bell RJ; Islam RM; Skiba MA; Davis SR
Hum Reprod; 2022 Mar; 37(3):622. PubMed ID: 35106571
[No Abstract] [Full Text] [Related]
25. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
26. Anti-Mullerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome.
Wetzka B; Textor W; Ochsner A; Geisthövel F
Eur J Endocrinol; 2011 Aug; 165(2):323-30. PubMed ID: 21602314
[TBL] [Abstract][Full Text] [Related]
27. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
Dewailly D; Gronier H; Poncelet E; Robin G; Leroy M; Pigny P; Duhamel A; Catteau-Jonard S
Hum Reprod; 2011 Nov; 26(11):3123-9. PubMed ID: 21926054
[TBL] [Abstract][Full Text] [Related]
29. Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome.
Kriseman M; Mills C; Kovanci E; Sangi-Haghpeykar H; Gibbons W
J Assist Reprod Genet; 2015 Sep; 32(9):1313-6. PubMed ID: 26238387
[TBL] [Abstract][Full Text] [Related]
30. Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndrome.
McCullough K; Ledger W
Womens Health (Lond); 2016 Jun; 12(3):263-5. PubMed ID: 27167142
[No Abstract] [Full Text] [Related]
31. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
[TBL] [Abstract][Full Text] [Related]
32. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
Yu M; Deng CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
[TBL] [Abstract][Full Text] [Related]
33. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
El-Mazny A; Abou-Salem N
Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
[TBL] [Abstract][Full Text] [Related]
34. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS).
Hart R; Doherty DA; Norman RJ; Franks S; Dickinson JE; Hickey M; Sloboda DM
Fertil Steril; 2010 Aug; 94(3):1118-21. PubMed ID: 20060112
[TBL] [Abstract][Full Text] [Related]
35. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D
J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
[TBL] [Abstract][Full Text] [Related]
36. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review.
Dumont A; Robin G; Catteau-Jonard S; Dewailly D
Reprod Biol Endocrinol; 2015 Dec; 13():137. PubMed ID: 26691645
[TBL] [Abstract][Full Text] [Related]
37. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
[TBL] [Abstract][Full Text] [Related]
38. Anti-Müllerian hormone as a marker of ovarian reserve: an update.
Robertson DM
Womens Health (Lond); 2008 Mar; 4(2):137-41. PubMed ID: 19072515
[TBL] [Abstract][Full Text] [Related]
39. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
[TBL] [Abstract][Full Text] [Related]
40. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.
Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
